203 related articles for article (PubMed ID: 429321)
1. Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
Shapiro RA; Clark VM; Curthoys NP
J Biol Chem; 1979 Apr; 254(8):2835-8. PubMed ID: 429321
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by glutamate of phosphate-dependent glutaminase of rat kidney.
Shapiro RA; Morehouse RF; Curthoys NP
Biochem J; 1982 Dec; 207(3):561-6. PubMed ID: 6131666
[TBL] [Abstract][Full Text] [Related]
3. Covalent interaction of L-2-amino-4-oxo-5-chloropentanoic acid with rat renal phosphate-dependent glutaminase. Evidence for a specific glutamate binding site and of subunit heterogeneity.
Shapiro RA; Clark VM; Curthoys NP
J Biol Chem; 1978 Oct; 253(19):7086-90. PubMed ID: 690141
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the hydrolysis and the covalent binding of 6-diazo-5-oxo-L-[6-14C]norleucine by rat renal phosphate-dependent glutaminase.
Clark VM; Shapiro RA; Curthoys NP
Arch Biochem Biophys; 1982 Jan; 213(1):232-9. PubMed ID: 6120680
[No Abstract] [Full Text] [Related]
5. Glutaminase inhibition and the release of neurotransmitter glutamate from synaptosomes.
Bradford HF; Ward HK; Foley P
Brain Res; 1989 Jan; 476(1):29-34. PubMed ID: 2563333
[TBL] [Abstract][Full Text] [Related]
6. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
Willis RC; Seegmiller JE
J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
[TBL] [Abstract][Full Text] [Related]
7. Properties of rat renal phosphate-dependent glutaminase coupled to Sepharose. Evidence that dimerization is essential for activation.
Morehouse RF; Curthoys NP
Biochem J; 1981 Mar; 193(3):709-16. PubMed ID: 7305957
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of renal gamma-glutamyl transferase by 6-diazo-5-oxo-L-norleucylglycine, an inactive precursor of affinity-labeling reagent.
Inoue M; Morino Y
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):46-9. PubMed ID: 6113588
[TBL] [Abstract][Full Text] [Related]
9. Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase.
Conti F; Minelli A
J Histochem Cytochem; 1994 Jun; 42(6):717-26. PubMed ID: 7910617
[TBL] [Abstract][Full Text] [Related]
10. Glutamine metabolism in bone.
Biltz RM; Letteri JM; Pellegrino ED; Palekar A; Pinkus LM
Miner Electrolyte Metab; 1983; 9(3):125-31. PubMed ID: 6135980
[TBL] [Abstract][Full Text] [Related]
11. Affinity labeling of rat-kidney gamma-glutamyl transpeptidase.
Inoue M; Horiuchi S; Morino Y
Eur J Biochem; 1977 Mar; 73(2):335-42. PubMed ID: 14827
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
Rosenfeld H; Roberts J
Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
[TBL] [Abstract][Full Text] [Related]
13. Glutamine- and N-acetyl-L-glutamate-dependent carbamoyl phosphate synthetase from Micropterus salmoides. Purification, properties, and inhibition by glutamine analogs.
Casey CA; Anderson PM
J Biol Chem; 1983 Jul; 258(14):8723-32. PubMed ID: 6602805
[TBL] [Abstract][Full Text] [Related]
14. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
Lebedeva ZI; Kabanova EA; Berezov TT
Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
[TBL] [Abstract][Full Text] [Related]
15. Glutamine as a precursor for transmitter glutamate, aspartate and GABA in the cerebellum: a role for phosphate-activated glutaminase.
Holten AT; Gundersen V
J Neurochem; 2008 Feb; 104(4):1032-42. PubMed ID: 17986214
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA).
Thangavelu K; Chong QY; Low BC; Sivaraman J
Sci Rep; 2014 Jan; 4():3827. PubMed ID: 24451979
[TBL] [Abstract][Full Text] [Related]
17. 6-diazo-5-oxo-L-norleucine and azaserine as affinity inhibitors of glutamin(asparagin)ase.
Lebedeva ZI; Kabanova EA; Berezov TT
Biochem Int; 1986 Mar; 12(3):413-20. PubMed ID: 3707592
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the glutamine site of Escherichia coli guanosine 5'-monophosphate synthetase.
Zalkin H; Truitt CD
J Biol Chem; 1977 Aug; 252(15):5431-6. PubMed ID: 18463
[TBL] [Abstract][Full Text] [Related]
19. Glutamate synthase. Properties of the glutamine-dependent activity.
Mäntsälä P; Zalkin H
J Biol Chem; 1976 Jun; 251(11):3294-9. PubMed ID: 6449
[TBL] [Abstract][Full Text] [Related]
20. Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursor.
Gao RD; Hin N; Prchalová E; Pal A; Lam J; Rais R; Slusher BS; Tsukamoto T
Bioorg Med Chem Lett; 2021 Oct; 50():128321. PubMed ID: 34400301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
